Why Changes are needed to Current Preformulation and Formulation Practices
Hosted By : Andrea CharlesMarch 15, 2011
Rate this Podcast:
(4.6 Stars | 16 Votes)
About this Podcast...
As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are needed to current preformulation and formulation practices, strategies to reduce time spent in R&D and importance of the role of co-crystals in formulation design and product development.
Horspool also shares his top 3 tips for evaluating the potential of new drug delivery technologies.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Rate this Podcast:
(4.6 Stars | 16 Votes)
Events of Interest
-
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches
February 9, 2012
Register Now -
Overcoming Common Lyophilization Scale-up Issues
November 15, 2011
Register Now -
Global HTA and CER Forum 2011
August 31, 2011
Register Now -
Digitalise your Business Development and Lead Generation Strategy
June 26, 2012
Register Now





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!